A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

Abroad (travel likely)Recruiting

Conditions

Lymphedema · Lymphedema, Breast Cancer · Lymphedema Arm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dung Nguyen, MD, PharmD, Palo Alto, California, United States
Contact: Study coordinator (Dung Nguyen, MD, PharmD) · info@koyamedical.com · 415-851-0337

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Fibrosis Syndrome · Lymphedema · Head &Amp; Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Boosted Compression for Lower Limb Chronic Edema

Chronic Edema · Lymphedema

Abroad (travel likely)Recruiting

Edegem, Belgium · Wilrijk, Belgium

Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani

Lymphedema · Lymphedema of Face · Internal Lymphedema

Abroad (travel likely)Recruiting

Kiel, Germany

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

Lymphedema, Breast Cancer · Lymphedema

Abroad (travel likely)Recruiting

San Francisco, United States